Richard M. Mariita has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bacteriological Profile and Antimicrobial Resistance Patterns of Pathogens Isolated from Patients with Infected Diabetic Foot Ulcers in Kisumu County, Kenya

    by Silas O. Awuor, Eric O. Omwenga, Eliud N. Wafula, Ibrahim I. Daud, Richard M. Mariita

    Background: Diabetic foot ulcers (DFUs) are a significant complication of diabetes and are frequently associated with bacterial infections that hinder healing and increase the risk of antimicrobial resistance (AMR). However, local data on pathogen distribution and resistance patterns remain limited in many resource-constrained settings. Methods: A cross-sectional study was conducted from March to June 2025 across three referral hospitals in Kisumu County, Kenya. A total of 471 patients with DFUs were recruited using a stratified sampling approach. Specimens were processed in accordance with the Clinical and Laboratory Standards Institute (CLSI) 2025 guidelines. Bacterial identification was performed using standard biochemical methods, and antimicrobial susceptibility testing was conducted using the Kirby–Bauer disk diffusion technique. Results: Out of 471 participants, 202 had culture-positive infections, yielding 221 bacterial isolates. Gram-negative organisms predominated, accounting for the majority of isolates. Escherichia coli and Acinetobacter baumannii were the most frequently isolated Gram-negative pathogens. Among Gram-positive bacteria, Staphylococcus aureus was the leading isolate and exhibited multidrug resistance (MDR). Conclusion: The predominance of Gram-negative pathogens and the presence of multidrug resistance highlight the limitations of empirical therapy in DFU management. These findings underscore the importance of routine microbiological testing and targeted antimicrobial stewardship strategies.

  • Open Access

    Pathways to Sustainable Biomanufacturing: Scalable Production of Biopharmaceutical Raw Materials and Biologics for Health Security

    by Jamie M. Reedy, Richard M. Mariita, Hyrine G. Munga, Britt Hafner

    The increasing global demand for biopharmaceutical biologics, including vaccines, monoclonal antibodies, enzymes, cytokines, hormones and growth factors, is driven by aging populations, rising cancer incidences, the persistent threat of pandemics such as COVID-19 and endemic infectious diseases such as Tuberculosis and Malaria. While the global biologics market is projected to surpass $1 trillion by 2034, current centralized manufacturing models rely heavily on resource-intensive mammalian systems that pose significant economic and logistical barriers, particularly for the Global South. This review evaluates the imperative for adopting sustainable biomanufacturing pathways to enhance global health security and sovereignty. We critically assess diverse production platforms, ranging from traditional microbial and mammalian cell lines to emerging green systems such as transgenic plants, algae, and cell-free synthesis, against the Triple Bottom Line framework: environmental stewardship, economic viability, and social responsibility. The analysis highlights that while mammalian cells remain the industry standard for complex post-translational modifications (PTMs), plant-based and cell-free platforms offer scalability, reduced carbon footprints, and the potential for decentralized production. Furthermore, the integration of artificial intelligence (AI), digital twins, and single-use technologies is identified as a catalyst for optimizing yield and facilitating net-zero emissions targets. For the Global South, these approaches offer opportunities to overcome resource limitations through localized, low-input platforms. We conclude that transitioning toward resilient, localized, and eco-friendly biomanufacturing is essential to mitigate supply chain vulnerabilities, ensure equitable access to life-saving therapeutics, and safeguard populations against future biological threats.

  • Open Access

    Global Health Alert: Racing to Control Antimicrobial-Resistant Candida auris and Healthcare Waste Disinfection Using UVC LED Technology

    by Jamie M. Reedy, Theekshana Fernando, Silas O. Awuor, Eric Omori Omwenga, Tatiana Koutchma, Richard M. Mariita

    Emerging antimicrobial-resistant (AMR) Candida auris presents a formidable global health challenge, causing severe healthcare-associated infections (HAIs) with high mortality rates. Its ability to colonize surfaces and resist standard disinfectants undermines traditional hygiene practices, prompting an urgent need for new strategies. Ultraviolet C (UVC) light offers a promising approach with rapid and broad-spectrum germicidal efficacy. This review examines current literature on UVC LED technology in combating C. auris, highlighting its effectiveness, limitations, and applications in healthcare hygiene. UVC light has potent activity against C. auris, with up to 99.9999% inactivation depending on certain conditions such as microbial load, type of organism, surface, environmental, equipment, and UVC radiation factors. UVC LEDs can effectively combat C. auris, driving down healthcare costs and reducing attributable global mortality. Here, we explore implementation strategies for the targeted disinfection of high-risk areas and equipment, air handling units (AHUs), and water treatment systems. Challenges associated with UVC LED disinfection devices in healthcare settings, current performance limitations, and radiation safety are discussed. This will help in optimizing application protocols for effective disinfection and radiation safety. To further strengthen healthcare facility hygiene practices and curb the global spread of C. auris, recommendations for integrating UVC LED disinfection into infection control programs are shared.


  • Open Access

    Global Health Alert: Racing to Control Antimicrobial Resistant Candida auris and Waste Using UVC LED Technology

    by Jamie M Reedy, Theekshana Fernando, Silas O Awuor, Eric Omori Omwenga, Tatiana Koutchma, Richard M Mariita

    The emergence of antimicrobial resistance (AMR) Candida auris presents a formidable global health challenge, causing severe healthcare-associated infections with high mortality rates. Its ability to colonize surfaces and resist standard disinfectants undermines traditional hygiene practices, prompting an urgent need for novel strategies. Ultraviolet C (UVC) light offers a promising approach due to its rapid and broad-spectrum germicidal efficacy. This review comprehensively examines the current knowledge of UVC LED technology in combating C. auris, highlighting its effectiveness, limitations, and potential applications in healthcare hygiene. UVC light has potent activity against C. auris, including multidrug-resistant (MDR) strains. UVC can reduce C. auris on contaminated surfaces, aiding in transmission prevention. This review explores implementation strategies, including mobile UVC systems for targeted disinfection of high-risk areas and equipment, integration into air handling units (AHUs) to continuously disinfect recirculating air, and incorporation into water treatment systems. Current limitations in our understanding of UVC safety and effectiveness necessitate further research to optimize application protocols and ensure treatment safety while maintaining efficacy against C. auris. Integrating UVC disinfection technology into infection control programs holds promise for strengthening hygiene practices that will curb the global spread of C. auris and improve patient outcomes.

  • Open Access

    Enhancing quality of life, public health, and economic development in the Global South through waterborne disease prevention with ultraviolet C light-emitting diode technology

    by Jamie M. Reedy, Dana Pousty, Beldeen W. Waliaula, Josephat Maniga, Hadas Mamane, Richard M. Mariita

    Waterborne diseases pose a significant public health challenge in the Global South, attributed to inadequate access to clean water, insufficient sanitation infrastructure, and poor water treatment systems. These factors contribute to the contamination of water sources with microbial pathogens, placing individuals at a heightened risk of contracting waterborne diseases. Waterborne diseases in the Global South are caused by various bacterial pathogens, parasites, and viruses, with factors such as climate change, water scarcity, and human pollution influencing their proliferation. Vulnerable populations, including children, pregnant women, and immunocompromised individuals, bear the brunt of these diseases, resulting in preventable deaths and hindering socioeconomic development due to health-care costs. Traditional methods for combating these diseases have limitations, leading to the need for alternative water disinfection strategies, such as ultraviolet C light-emitting diodes (UVC LEDs). This review examines both the current state of waterborne diseases in the Global South (i.e., disease prevalence, causes, and public/systemic impacts) and the current landscape of UVC LED technology for water disinfection. Through the lens of this multi-focus review, we also explore the potential widespread implementation of UVC LED technology for water disinfection as a method of combating waterborne diseases to improve public health outcomes. Regulatory frameworks for UVC LED water treatment systems in the Global South remain limited. To address this limitation, we recommend an essential implementation framework that includes legislation, partnerships, sustainability, affordability, industrial and environmental standards, and robust evaluation protocols. Finally, we provide a substantial overview of the future directions and research opportunities in UVC LED technology and water treatment mechanisms aiming for promising public health outcomes. Embracing UVC LED technology can help address persistent disease challenges and improve public health in regions with limited infrastructure, thereby moving closer to achieving the United Nation’s Sustainable Development Goals and emphasizing the significance of universal access to improved WASH (safe water, sanitation, and hygiene) conditions.


  • Open Access

    Monitoring the battleground: exploring antimicrobial resistance and virulence factors in wound bacterial isolates

    by Silas Onyango Awuor, Eric O. Omwenga, Richard M. Mariita, Jonathan M. Musila, Stanslaus Musyoki

    Antibiotic resistance poses a grave global public health threat, exacerbated by widespread and often inappropriate antibiotic usage. Vigilant surveillance of antibiotic utilization and emergence of antimicrobial resistance (AMR) is essential. Of particular concern in the era of AMR is the persistent issue of chronic wound infections. To address this, we conducted a comprehensive evaluation of wound isolates from chronic wounds at Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) in Kenya, to identify relevant bacteria and assess their drug resistance patterns.Wound samples were collected and processed using standard microbiological methods. Bacterial isolates were identified and assessed for their susceptibility to a panel of antibiotics using the Kirby-Bauer disk diffusion method. A total of 103 bacterial isolates were obtained from the wound samples, with a higher prevalence in male patients (59%). Staphylococcus aureus (20.7 %) emerged as the most predominant pathogen, followed by Klebsiella spp. (14.8 %), Pseudomonas aeruginosa spp. (14.8 %) and Escherichia coli (4.4 %) in wound samples. High levels of antibiotic resistance were observed among the isolates, with the highest resistance rates reported for cotrimoxazole (48.1 %), clindamycin (25.9 %) and erythromycin (25.9 %). Furthermore, among the isolates, 75 % produced haemolysin and protease, while 50 % produced lipase and phospholipase, factors that enhance virulence and survival. The findings of this study highlight the alarmingly high prevalence of antibiotic resistance among bacterial pathogens isolated from chronic wounds in Kenya. This poses a major challenge to the effective management of chronic wound infections. There is an urgent need to implement effective antimicrobial stewardship programs and develop new antibiotics to combat the growing threat of antibiotic resistance.


  • Open Access

    Water and foodborne bacterial pathogens isolated from hospitalized children are extensively resistance against commonly used Penicillin-type antibiotics in developing countries

    by Silas Onyango Awuor, Eric O. Omwenga, Richard M. Mariita, Jonathan M. Musila, Alexander Mbeke, Thommas M. Musyoka

    Diarrheal diseases pose a significant threat to children under five years, ranking as the second leading cause of death in this age group. This is partly attributed to the rise of multidrug-resistant enteric bacteria that has further exacerbated the current global health crisis. We herein report a study aimed at identifying common diarrhea-causing bacteria and assessing their antibiotic susceptibility patterns in children under five seeking medical care at Muhoroni County Hospital. Between January and June 2016, a total of 196 under-five children seeking medical care were enrolled with parental or guardian consent. Stool samples were collected and subjected to culture and biochemical tests using standard protocols. Susceptibility testing was performed using conventional antibiotics. Among the participants (196), 125 (63.8%) were from pediatric outpatient departments, while 71 (36.2%) were from pediatric emergency departments. The study population consisted of 105 (53.6%) males and 91 (46.4%) females. Enteric bacterial pathogens were identified in 43 (21.9%) of the samples, with Escherichia coli accounting for 25 (12.8%), Shigella spp. for 11 (5.6%), and Salmonella spp. for 7 (3.6%). All isolated E. coli, Shigella spp., and Salmonella spp. exhibited susceptibility to Ceftriaxone. Notably, 14 (56%) and 13 (52%) of E. coli isolates demonstrated resistance to Amoxicillin and Ampicillin, respectively. The findings provide insights into the distribution of bacteria causing diarrhea in children under five, and associated antibiotic resistance profiles. The investigation highlights an urgent need for effective surveillance on bacterial pathogenicity among children below 5 years, antimicrobial stewardship, and alternative treatment strategies to combat the growing threat of multidrug-resistant enteric bacteria in this vulnerable population.

  • Open Access

    Monitoring the battleground: Antimicrobial resistance, antibiofilm patterns, and virulence factors of wound bacterial isolates from patients in hospital system

    by Silas O. Awuor, Richard Mariita, Eric O. Omwenga, Jonathan Musila, Stanslaus Musyoki

    Extensive use of antibiotics in the treatment of bacterial infections has led to a challenge of antibiotic resistance, contributing to morbidity and mortality. Herein, evaluation of bacterial isolates from patients with wound discharge was performed and drug susceptibility patterns examined, with a goal of deciphering antibacterial resistance. A cross-sectional study was conducted between March to June 2022, in which samples were collected from patients with chronic wounds and were inoculated into appropriate media for identification and characterization. The bacterial pathogens were identified using standard microbiological methods. Shockingly, the majority of wound isolates showed positive growth in microbial analysis with high prevalence in male candidates. Further, Staphylococcus aureus 28 (20.7%) was identified as the most predominant pathogen followed by Klebsiella spp . 20 (14.8%), P. aeruginosa spp . 10 (14.8%) and lastly E. coli 6 (4.4%) bacteria in the wound isolates while cotrimoxazole 13 (48.1%) followed by clindamycin 7 (25.9%) and erythromycin 7 (25.9%) were the most antibacterial resistant drugs to both Gram positive and Gram-negative bacteria. Out of the four isolates, 3 (75%) isolates were able to produce the haemolysin and protease and 2 (50%) isolates were able to produce the lipase and phospholipase. The findings herein form a clinical basis for identification of antimicrobial resistance in chronic wounds that can be applied in responsible use of antibacterial in chronic wound management and as an illumination in development of more potent antibiotics for chronic wound treatment


  • Open Access

    Towards a Healthy Car: UVC LEDs in an Automobile’s HVAC Demonstrates Effective Disinfection of Cabin Air

    by Richard M. Mariita, James H. Davis, Michelle M. Lottridge, Rajul V. Randive, Hauke Witting, Johannes Yu

    Vehicle Heating, ventilation, and air conditioning (HVAC) systems can accumulate and recirculate highly infectious respiratory diseases via aerosols. Integrating Ultraviolet Subtype C (UVC) light-emitting diodes (LEDs) to complement automobile HVAC systems can protect occupants from developing allergies, experiencing inflammatory problems, or acquiring respiratory infectious diseases by inactivating pathogenic organisms. UVC can add little to no static pressure with minimal space, unlike mercury lamps which are larger and heavier. Additionally, UVC LEDs are effective at low voltage and have no mercury or glass. While previous experiments have shown UVC LED technology can reduce bacteriophage Phi6 concentrations by 1 log in 5 min (selected as the average time to clean the cabin air), those studies had not positioned LED within the HVAC itself or studied the susceptibility of the surrogate at the specific wavelength. This study aimed to assess the disinfection performance of UVC LEDs in automotive HVAC systems and determine the dose–response curve for bacteriophage Phi6, a SARS-CoV-2 surrogate. To achieve this, UVC LEDs were installed in a car HVAC system. To determine inactivation efficacy, a model chamber of 3.5 m3, replicating the typical volume of a car, containing the modified automobile HVAC system was filled with bacteriophage Phi6, and the HVAC was turned on with and without the UVC LEDs being turned on. The results revealed that HVAC complemented with UVC reduced bacteriophage Phi6 levels significantly more than the HVAC alone and reduced the viral concentration in the cabin by more than 90% viral reduction in less than 5 min. The performance after 5 min is expected to be significantly better against SARS-CoV-2 because of its higher sensitivity to UVC, especially at lower wavelengths (below 270 nm). HVAC alone could not achieve a 90% viral reduction of bacteriophage Phi6 in 15 min. Applying UVC LEDs inside an HVAC system is an effective means of quickly reducing the number of aerosolized viral particles in the chamber, by inactivating microorganisms leading to improved cabin air quality.


  • Open Access

    Towards a Healthy Car: UVC LEDs Inside Automobile HVAC Chamber Offers Effective Complementary Disinfection to Ensure Clean Cabin Air

    by Richard Mariita, James H. Davis, Michelle M. Lottridge, Rajul V. Randive, Hauke Witting, Johannes Yu

    Vehicle HVAC systems can accumulate and recirculate highly infectious respiratory diseases via aerosols. Integrating UVC to complement automobile HVAC systems can protect occupants from developing allergies, experiencing inflammatory problems, or acquiring respiratory infectious diseases by inactivating pathogenic organisms. UVC can add little to no static pressure with minimal space, unlike mercury lamps which are larger and heavier. Additionally, UVC LEDs are effective at low voltage and have no mercury or glass. While previous experiments have shown UVC LED technology can reduce bacteriophage Phi6 concentrations by 1 log in 5 minutes (selected as the average time to clean the cabin air), those studies had not positioned LED within the HVAC itself or studied the susceptibility of the surrogate at the specific wavelength. This study aimed to assess the disinfection performance of UVC LEDs in automotive HVAC systems and determine the dose-response curve for bacteriophage Phi6, a SARS-CoV-2 surrogate. To achieve this, UVC LEDs were installed in a car HVAC system. To determine inactivation efficacy, a model chamber of 3.5 m3, replicating the typical volume of a car, containing the modified automobile HVAC system was filled with bacteriophage Phi6, and the HVAC was turned on with and without the UVC LEDs being turned on. The results revealed that HVAC complemented with UVC reduced bacteriophage Phi6 levels significantly more than the HVAC alone and reduced the viral concentration in the cabin by more than 1 LRV (90% viral reduction) in less than 5 minutes. The performance after 5 minutes is expected to be significantly better against SARS-CoV-2 because of its higher sensitivity to UVC, especially at lower wavelengths (below 270 nm). HVAC alone could not achieve a 90% viral reduction of bacteriophage Phi6 in 15 minutes. Applying UVC LEDs inside an HVAC system is an effective means of quickly reducing the number of aerosolized viral particles in the chamber, by inactivating microorganisms leading to improved cabin air quality.